Agro-Bio Antibodies is a pioneering company in the field of antibodies, offering expertise and know-how for the production, development, and characterization of antibodies. With over 40 years of experience, the team at Agro-Bio supports pharmaceutical and in vitro diagnostic industries, as well as public institutions, in addressing immunology challenges, providing tailored and effective solutions. Their services encompass bioanalysis/biopharma and in vitro diagnostics, including anti-idiotypic antibodies, host cell protein issue management, epitope mapping, and in vitro production. The company's key strengths lie in its extensive experience, responsive and multi-skilled team, certifications, research tax credit approval, preserved intellectual property and confidentiality, transparency, and royalty-free services. Agro-Bio Antibodies is headquartered in France and operates in the Biopharma and Biotechnology sectors. With null disclosed information on the last investment and the investors, the company's potential for growth and future funding opportunities piques the interest of venture capital firms.
There is no investment information
No recent news or press coverage available for Agro-Bio Antibodies.